Updating results

6966 results

Sort: Relevance | Date

Staffing

All NICE products on staffing. Includes any guidance and NICE Pathways.

Surgical care

All NICE products on surgical care. Includes any guidance, advice, NICE Pathways and quality standards.

Uterine prolapse

All NICE products on uterine prolapse. Includes any guidance and NICE Pathways.

Thyroid disorders

All NICE products on thyroid disorders. Includes any guidance, advice and NICE Pathways.

Lower urinary tract symptoms

All NICE products on Lower urinary tract symptoms. Includes any guidance, advice, NICE Pathways and quality standards.

Metastases

All NICE products on Metastases. Includes any guidance, advice, NICE Pathways and quality standards.

Hypertension in pregnancy: diagnosis and management (Update)

In development [GID-NG10083] Expected publication date: 25 June 2019

NICE guideline In development

Depression in children and young people: identification and management

In development [GID-NG10106] Expected publication date: 25 June 2019

NICE guideline In development

Reinforcement of permanent stomas with mesh to prevent parastomal hernias

In development [GID-IPG10105] Expected publication date: 26 June 2019

Interventional procedures guidance In development

Cardiac contractility modulation device implantation for heart failure

In development [GID-IPG10106] Expected publication date: 26 June 2019

Interventional procedures guidance In development

Transcatheter valve-in-valve implantation for the treatment of aortic bioprosthetic valve dysfunction

In development [GID-IPG10107] Expected publication date: 26 June 2019

Interventional procedures guidance In development

Multiple myeloma (newly diagnosed) - lenalidomide [ID474]

In development [GID-TAG429] Expected publication date: 26 June 2019

Technology appraisal guidance In development

Multiple myeloma - lenalidomide (post bortezomib) (part rev TA171) [ID667]

In development [GID-TAG452] Expected publication date: 26 June 2019

Technology appraisal guidance In development

Nusinersen for treating spinal muscular atrophy ID1069

In development [GID-TA10281] Expected publication date: 26 June 2019

Technology appraisal guidance In development

Dementia (update)

In development [GID-QS10079] Expected publication date: 28 June 2019

Quality standard In development

Abdominal aortic aneurysm: diagnosis and management

In development [GID-CGWAVE0769] Expected publication date: 03 July 2019

NICE guideline In development

Cemiplimab for treating cutaneous squamous cell carcinoma [ID1367]

In development [GID-TA10304] Expected publication date: 03 July 2019

Technology appraisal guidance In development

Pembrolizumab with carboplatin and paclitaxel for untreated squamous non-small-cell lung cancer [ID1306]

In development [GID-TA10245] Expected publication date: 04 July 2019

Technology appraisal guidance In development

Pregnancy and complex social factors: a model for service provision for pregnant women with complex social factors (CG110)

This guideline covers antenatal care for all pregnant women with complex social factors (particularly alcohol or drug misuse, recent migrant or asylum seeker status, difficulty reading or speaking English, aged under 20, domestic abuse). It offers advice on improving access to care, maintaining contact with antenatal carers, and additional information and support for these women.

Clinical guideline Published September 2010

Sedation in under 19s: using sedation for diagnostic and therapeutic procedures (CG112)

This guideline covers the assessment, preparation, training and monitoring needed when using sedation in people aged under 19. It aims to help healthcare professionals decide when sedation is the most clinically and cost effective option for reducing pain and anxiety during operations for children and young people.

Clinical guideline Published December 2010

Generalised anxiety disorder and panic disorder in adults: management (CG113)

This guideline covers the care and treatment of people aged 18 and over with generalised anxiety disorder (chronic anxiety) or panic disorder (with or without agoraphobia or panic attacks). It aims to help people achieve complete relief of symptoms (remission), which is associated with better functioning and a lower likelihood of relapse.

Clinical guideline Published January 2011

Healthcare-associated infections: prevention and control in primary and community care (CG139)

This guideline covers preventing and controlling healthcare-associated infections in children, young people and adults in primary and community care settings. It provides a blueprint for the infection prevention and control precautions that should be applied by everyone involved in delivering NHS care and treatment.

Clinical guideline Published March 2012 Last updated February 2017

Palliative care for adults: strong opioids for pain relief (CG140)

This guideline covers safe and effective prescribing of strong opioids for pain relief in adults with advanced and progressive disease. It aims to clarify the clinical pathway for prescribing and help to improve pain management and patient safety. Care during the last 2 to 3 days of life is covered by care of dying adults in the last days of life.

Clinical guideline Published May 2012 Last updated August 2016

Acute upper gastrointestinal bleeding in over 16s: management (CG141)

This guideline covers how upper gastrointestinal bleeding can be effectively managed in adults and young people aged 16 years and older. It aims to identify which diagnostic and therapeutic steps are useful so hospitals can develop a structure in which clinical teams can deliver an optimum service for people who develop this condition.

Clinical guideline Published June 2012 Last updated August 2016

Autism spectrum disorder in adults: diagnosis and management (CG142)

This guideline covers diagnosing and managing suspected or confirmed autism spectrum disorder (autism, Asperger’s syndrome and atypical autism) in people aged 18 and over. It aims to improve access and engagement with interventions and services, and the experience of care, for people with autism.

Clinical guideline Published June 2012 Last updated August 2016

Sickle cell disease: managing acute painful episodes in hospital (CG143)

This guideline covers managing acute painful sickle cell episodes in children, young people and adults who present at hospital, from presentation until when they are discharged. It aims to reduce variation in how acute episodes are managed in hospital, focusing on effective, prompt and safe pain relief.

Clinical guideline Published June 2012

Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (CG144)

This guideline covers the diagnosis and management of venous thromboembolic diseases in adults (aged 18 and over), and the role of thrombophilia testing. It aims to clarify which diagnostic tests should be used, reduce variation in pharmacological therapies, and provide guidance on when thrombophilia testing is useful.

Clinical guideline Published June 2012 Last updated November 2015

Psychosis and schizophrenia in adults: prevention and management (CG178)

This guideline covers recognising and managing psychosis and schizophrenia in adults. It aims to improve care through early recognition and treatment, and by focusing on long-term recovery. It also recommends checking for coexisting health problems and providing support for family members and carers.

Clinical guideline Published February 2014 Last updated March 2014

Pressure ulcers: prevention and management (CG179)

This guideline covers risk assessment, prevention and treatment in children, young people and adults at risk of, or who have, a pressure ulcer (also known as a bedsore or pressure sore). It aims to reduce the number of pressure ulcers in people admitted to secondary or tertiary care or receiving NHS care in other settings, such as primary and community care and emergency departments.

Clinical guideline Published April 2014

Atrial fibrillation: management (CG180)

This guideline covers diagnosing and managing atrial fibrillation in adults. It aims to ensure that people receive the best management to help prevent harmful complications, in particular stroke and bleeding.

Clinical guideline Published June 2014 Last updated August 2014

Spasticity in under 19s: management (CG145)

This guideline covers managing spasticity and co-existing motor disorders and their early musculoskeletal complications in children and young people (from birth up to their 19th birthday) with non-progressive brain disorders. It aims to reduce variation in practice and help healthcare professionals to select and use appropriate treatments.

Clinical guideline Published July 2012 Last updated November 2016

Osteoporosis: assessing the risk of fragility fracture (CG146)

This guideline covers assessing the risk of fragility fracture in people aged 18 and over with osteoporosis. It aims to provide guidance on the selection and use of risk assessment tools in the care of adults at risk of fragility fractures in all NHS settings.

Clinical guideline Published August 2012 Last updated February 2017

Peripheral arterial disease: diagnosis and management (CG147)

This guideline covers diagnosing and managing peripheral arterial disease (PAD) in people aged 18 and over. Rapid changes in diagnostic methods, endovascular treatments and vascular services associated with new specialties in surgery and interventional radiology have resulted in considerable uncertainty and variation in practice. This guideline aims to resolve that uncertainty and variation.

Clinical guideline Published August 2012 Last updated February 2018

Urinary incontinence in neurological disease: assessment and management (CG148)

This guideline covers assessing and managing urinary incontinence in children, young people and adults with neurological disease. It aims to improve care by recommending specific treatments based on what symptoms and neurological conditions people have.

Clinical guideline Published August 2012

Neonatal infection (early onset): antibiotics for prevention and treatment (CG149)

This guideline covers preventing infection within 72 hours of birth in healthy babies, treating pregnant women whose baby is at risk, and caring for babies who have a suspected or confirmed infection. It aims to reduce delays in recognising and treating sick babies and prevent unnecessary use of antibiotics.

Clinical guideline Published August 2012

Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): diagnosis and management (CG53)

This guideline covers diagnosing and managing chronic fatigue syndrome (CFS) which is also known as myalgic encephalomyelitis (ME) (or encephalopathy). It aims to improve the quality of life for people with CFS/ME by setting out the care and treatment options that should be available for them.

Clinical guideline Published August 2007

Atopic eczema in under 12s: diagnosis and management (CG57)

This guideline covers diagnosing and managing atopic eczema in children under 12. It aims to improve care for children with atopic eczema by making detailed recommendations on treatment and specialist referral. The guideline also explains how healthcare professionals should assess the effect eczema has on quality of life, in addition to its physical severity.

Clinical guideline Published December 2007

Postnatal care up to 8 weeks after birth (CG37)

This guideline covers the routine postnatal care women and their babies should receive for 6–8 weeks after the birth. It includes advice given on breastfeeding, and the management of common and serious health problems in women and their babies after the birth.

Clinical guideline Published July 2006 Last updated February 2015

Pneumonia in adults: diagnosis and management (CG191)

This guideline covers diagnosing and managing community- and hospital-acquired pneumonia in adults. It aims to improve accurate assessment and diagnosis of pneumonia to help guide antibiotic prescribing and ensure that people receive the right treatment.

Clinical guideline Published December 2014

Acutely ill adults in hospital: recognising and responding to deterioration (CG50)

This guideline covers how patients in hospital should be monitored to identify those whose health may become worse suddenly and the care they should receive. It aims to reduce the risk of patients needing to stay longer in hospital, not recovering fully or dying. It doesn’t specifically cover the care of children, patients in critical care areas or those in the final stages of a terminal illness.

Clinical guideline Published July 2007

Drug misuse in over 16s: psychosocial interventions (CG51)

This guideline covers using psychosocial interventions to treat adults and young people over 16 who have a problem with or are dependent on opioids, stimulants or cannabis. It aims to reduce illicit drug use and improve people’s physical and mental health, relationships and employment.

Clinical guideline Published July 2007

Drug misuse in over 16s: opioid detoxification (CG52)

This guideline covers helping adults and young people over 16 who are dependent on opioids to stop using drugs. It aims to reduce illicit drug use and improve people’s physical and mental health, relationships and employment.

Clinical guideline Published July 2007

Intrapartum care for healthy women and babies (CG190)

This guideline covers the care of healthy women and their babies, during labour and immediately after the birth. It focuses on women who give birth between 37 and 42 weeks of pregnancy (‘term’). The guideline helps women to make an informed choice about where to have their baby. It also aims to reduce variation in areas of care such as fetal monitoring during labour and management of the third stage of labour.

Clinical guideline Published December 2014 Last updated February 2017

Obesity prevention (CG43)

This guideline covers preventing children, young people and adults becoming overweight or obese. It outlines how the NHS, local authorities, early years’ settings, schools and workplaces can increase physical activity levels and make dietary improvements among their target populations.

Clinical guideline Published December 2006 Last updated March 2015

Faecal incontinence in adults: management (CG49)

This guideline covers assessing and managing faecal incontinence (any involuntary loss of faeces that is a social or hygienic problem) in people aged 18 and over. It aims to ensure that staff are aware that faecal incontinence is a sign or a symptom, not a diagnosis.

Clinical guideline Published June 2007

Hypertension in adults: diagnosis and management (CG127)

This guideline covers identifying and treating primary hypertension (high blood pressure) in people aged 18 and over. It aims to reduce the risk of cardiovascular problems such as heart attacks and strokes by helping healthcare professionals to diagnose hypertension accurately and treat it effectively. It also aims to reduce unnecessary treatment by improving the way blood pressure is measured.

Clinical guideline Published August 2011 Last updated November 2016

Social anxiety disorder: recognition, assessment and treatment (CG159)

This guideline covers recognising, assessing and treating social anxiety disorder (also known as ‘social phobia’) in children and young people (from school age to 17 years) and adults (aged 18 years and older). It aims to improve symptoms, educational, occupational and social functioning, and quality of life in people with social anxiety disorder.

Clinical guideline Published May 2013

Self-harm in over 8s: short-term management and prevention of recurrence (CG16)

This guideline covers the short-term management and prevention of self-harm in people aged 8 and over, regardless of whether accompanied by mental illness. It covers the first 48 hours following an act of self-harm, but does not address the longer-term psychiatric care of people who self-harm.

Clinical guideline Published July 2004

Multiple sclerosis in adults: management (CG186)

This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over. It aims to improve the quality of life for adults with multiple sclerosis by promoting symptom management, comprehensive reviews and effective relapse treatment.

Clinical guideline Published October 2014

Chronic kidney disease in adults: assessment and management (CG182)

This guideline covers the care and treatment of people with, or at risk of developing, chronic kidney disease. It aims to prevent or delay the progression of chronic kidney disease, reduce or prevent the development of complications, and reduce the risk of cardiovascular disease.

Clinical guideline Published July 2014 Last updated January 2015